PrimeBioMed Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • 2ndary - Private

PrimeBioMed General Information

Description

Developer of molecular-cell diagnostic technology intended to provide antibodies for cancer diagnosis. The company's technology uses recombinant diagnosis and long-established hybridoma lines for the development of antibodies, enabling healthcare providers to treat cancer in an effective way.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • Nauchny pr., 20, building 3
  • Moscow, 117246
  • Russia
+7 8
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • Nauchny pr., 20, building 3
  • Moscow, 117246
  • Russia
+7 8

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PrimeBioMed Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private 01-Sep-2024 Completed Generating Revenue
3. Early Stage VC 25-Sep-2017 Completed Generating Revenue
2. Early Stage VC $2.02M Completed Startup
1. Early Stage VC (Series A) 01-Jan-2013 $2.02M $2.02M Completed Startup
To view PrimeBioMed’s complete valuation and funding history, request access »

PrimeBioMed Patents

PrimeBioMed Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2019004875-A1 Mouse hybridoma ykl-39, clone 1b2 g4 - producer of monoclonal antibody having specificity toward human cytoplasmic antigen ykl-39 Inactive 28-Jun-2017

PrimeBioMed Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PrimeBioMed FAQs

  • When was PrimeBioMed founded?

    PrimeBioMed was founded in 2013.

  • Where is PrimeBioMed headquartered?

    PrimeBioMed is headquartered in Moscow, Russia.

  • What is the size of PrimeBioMed?

    PrimeBioMed has 5 total employees.

  • What industry is PrimeBioMed in?

    PrimeBioMed’s primary industry is Biotechnology.

  • Is PrimeBioMed a private or public company?

    PrimeBioMed is a Private company.

  • What is PrimeBioMed’s current revenue?

    The current revenue for PrimeBioMed is .

  • How much funding has PrimeBioMed raised over time?

    PrimeBioMed has raised $2.02M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process